These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 22544233)
1. The patient, the physician, and the payor: a multiperspective look at the challenges of treating primary immunodeficiency. Ballow M J Clin Immunol; 2012 Sep; 32 Suppl 2():S421-2. PubMed ID: 22544233 [No Abstract] [Full Text] [Related]
3. Payor issues: barriers to optimal management of patients with primary immunodeficiency. Shapiro RS; Boyle M J Clin Immunol; 2012 Sep; 32 Suppl 2():S410-4. PubMed ID: 22918575 [TBL] [Abstract][Full Text] [Related]
4. Dosing and therapy utilization: a discussion of updates on PI treatment guidelines. Ballow M J Clin Immunol; 2012 Sep; 32 Suppl 2():S415-20. PubMed ID: 22730010 [TBL] [Abstract][Full Text] [Related]
5. The use of immunoglobulin therapy for patients with primary immune deficiency: an evidence-based practice guideline. Shehata N; Palda V; Bowen T; Haddad E; Issekutz TB; Mazer B; Schellenberg R; Warrington R; Easton D; Anderson D; Hume H Transfus Med Rev; 2010 Jan; 24 Suppl 1():S28-50. PubMed ID: 19962579 [TBL] [Abstract][Full Text] [Related]
6. Critical issues and needs in management of primary immunodeficiency diseases in Latin America. Condino-Neto A; Franco JL; Trujillo-Vargas C; Espinosa-Rosales FJ; Leiva LE; Rodriguez-Quiroz F; King A; Lagos M; Oleastro M; Bezrodnik L; Grumach AS; Costa-Carvalho BT; Sorensen RU Allergol Immunopathol (Madr); 2011; 39(1):45-51. PubMed ID: 21167629 [TBL] [Abstract][Full Text] [Related]
7. Local and national advocacy support. Shapiro RS; Boyle M; Perez EE J Clin Immunol; 2012 Sep; 32 Suppl 2(Suppl 2):S423-6. PubMed ID: 22810627 [TBL] [Abstract][Full Text] [Related]
8. Kiovig for primary immunodeficiency: reduced infusion and decreased costs per infusion. Connolly M; Simoens S Int Immunopharmacol; 2011 Sep; 11(9):1358-61. PubMed ID: 21570491 [TBL] [Abstract][Full Text] [Related]
11. [The use of intravenous immunoglobulins in the treatment of primary immunodeficiencies]. Lewandowicz-Uszyńska A; Jankowski A Pol Merkur Lekarski; 2011 Jun; 30(180):409-12. PubMed ID: 21751549 [TBL] [Abstract][Full Text] [Related]
12. The pocketbook: Pharmacoeconomic issues related to intravenous immunoglobulin therapy. Mahadevia PJ Pharmacotherapy; 2005 Nov; 25(11 Pt 2):94S-100S. PubMed ID: 16229680 [TBL] [Abstract][Full Text] [Related]
13. [Treatment of patients with primary antibody deficiencies in Germany]. Borte M; Oertelt C; Högy B Klin Padiatr; 2005; 217(5):276-80. PubMed ID: 16167275 [TBL] [Abstract][Full Text] [Related]
14. Pharmacoeconomics of immunoglobulins in primary immunodeficiency. Simoens S Expert Rev Pharmacoecon Outcomes Res; 2009 Aug; 9(4):375-86. PubMed ID: 19670998 [TBL] [Abstract][Full Text] [Related]
15. Use of intravenous immunoglobulin G (IVIG). Looney RJ; Huggins J Best Pract Res Clin Haematol; 2006; 19(1):3-25. PubMed ID: 16377538 [TBL] [Abstract][Full Text] [Related]
16. Treatment of primary immunodeficiency with Kiovig: a literature review. Simoens S Adv Ther; 2010 Mar; 27(3):142-9. PubMed ID: 20422472 [TBL] [Abstract][Full Text] [Related]
17. [Economic evaluation of at home subcutaneous and intravenous immunoglobulin substitution]. Haddad L; Perrinet M; Parent D; Leroy-Cotteau A; Toguyeni E; Condette-Wojtasik G; Hachulla E Rev Med Interne; 2006 Dec; 27(12):924-6. PubMed ID: 17011081 [TBL] [Abstract][Full Text] [Related]
18. Physician needs in health informatics: just ask the docs. Dinakarpandian D; Williams AR; Dinakar C J Allergy Clin Immunol; 2010 Jun; 125(6):1401-1403.e4. PubMed ID: 20434200 [No Abstract] [Full Text] [Related]